HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection.

Abstract
Successful vaccines (i.e., tetanus and diphtheria) can induce long-lived Ab levels that are maintained by bone marrow plasma cells and plasma Ab levels do not correlate with numbers of blood memory B cells. Destruction of CD4(+) T cells early in HIV-1 acute infection may result in insufficient induction of neutralizing Ab responses; thus, an HIV-1 vaccine should elicit high levels of durable Abs by long-lived plasma cells to be protective. We asked if HIV-1 envelope-specific memory responses were sustained by memory B cells in the settings of HIV-1 gp120 envelope vaccination and chronic HIV-1 infection. Levels of anti-HIV-1 envelope plasma Abs and memory B cells were found to correlate in both settings. Moreover, whereas the expected half-life of plasma Ab levels to protein vaccines was >10 years when maintained by long-lived plasma cells, anti-envelope Ab level half-lives were approximately 33-81 wk in plasma from antiretroviral drug-treated HIV-1(+) subjects. In contrast, anti-p55 Gag Ab level half-life was 648 wk, and Ab titers against influenza did not decay in-between yearly or biennial influenza vaccine boosts in the same patients. These data demonstrated that HIV-1 envelope induces predominantly short-lived memory B cell-dependent plasma Abs in the settings of envelope vaccination and HIV-1 infection. The inability to generate high titers of long-lived anti-envelope Abs is a major hurdle to overcome for the development of a successful HIV-1 vaccine.
AuthorsMattia Bonsignori, M Anthony Moody, Robert J Parks, T Matt Holl, Garnett Kelsoe, Charles B Hicks, Nathan Vandergrift, Georgia D Tomaras, Barton F Haynes
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 183 Issue 4 Pg. 2708-17 (Aug 15 2009) ISSN: 1550-6606 [Electronic] United States
PMID19625640 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • AIDS Vaccines
  • HIV Antibodies
  • HIV Envelope Protein gp120
Topics
  • AIDS Vaccines (administration & dosage, immunology)
  • Adult
  • Amino Acid Sequence
  • B-Lymphocyte Subsets (immunology, metabolism, virology)
  • Cells, Cultured
  • Chronic Disease
  • Female
  • HIV Antibodies (biosynthesis, blood)
  • HIV Envelope Protein gp120 (administration & dosage, immunology)
  • HIV Infections (immunology, prevention & control, virology)
  • HIV-1 (immunology)
  • Humans
  • Immunologic Memory
  • Male
  • Middle Aged
  • Molecular Sequence Data

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: